HR68, a derivative of the peroxisome proliferator-activated receptor (PPAR) agonist fenofibric acid, serves as an anticancer agent. It effectively reduces the viability of LN-229 glioblastoma cells, with an IC50 value of 1.17 µM. Notably, HR68 is capable of crossing the blood-brain barrier in temozolomide-resistant orthotopic patient-derived xenograft (PDX) mouse models of glioblastoma.
Molecular Weight:
394.85
CAS Number:
[2454582-64-8]
Formula:
C22H19ClN2O3
Target:
Others
T83912
* VAT and and shipping costs not included. Errors and price changes excepted